Olivier Terrier
8Patents
1h-index
15Co-inventors
44Inventor score
Filing activity: Jul 18, 2008 → Jul 12, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9381238B2 | Method for improving the production of influenza viruses and vaccine seeds | Chemistry; Metallurgy | 3 | Active |
| US11351180B2 | Antiviral compositions for treating the flu | Human Necessities | 1 | Active |
| US8927701B2 | HPIV-2 variants and their medical applications | Chemistry; Metallurgy | 0 | Active |
| US8926988B2 | Mutant proteins of the F protein of PIV-5 and PIV-2 | Chemistry; Metallurgy | 0 | Active |
| US11510896B2 | Antiviral compositions for the treatment of infections linked to coronaviruses | Human Necessities | 0 | Active |
| US8906386B2 | Mutant proteins of the F protein of PIV-5 and PIV-2 | Chemistry; Metallurgy | 0 | Active |
| US11504424B2 | Attenuated virus strain and use thereof as a vaccine | Chemistry; Metallurgy | 0 | Active |
| US12285433B2 | Diltiazem for use in the treatment of microbial infections | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.